
Journal of Pharmaceutical Sciences p. 365 - 374 (1985)
Update date:2022-08-04
Topics:
Anderson
Conradi
Knuth
The ideal water-soluble prodrug should exhibit sufficient aqueous solution stability to allow long-term storage of its solutions (i.e., 2 years at room temperature) and yet should be converted rapidly in vivo to the active parent drug - two severe and seemingly conflicting demands which limit the utility of many common solubilizing pro-moieties. For example, succinate esters, which are commonly utilized as water-soluble prodrugs, are unstable in solution and may undergo slow and incomplete bioconversion in vivo. In this study, the solution stability problems associated with 21-esters of corticosteroids are reviewed. It is concluded that the most important reaction limiting shelf life is ester hydrolysis. From a consideration of the influence of molecular structure on ester reactivity, a strategy for the design of solution-stable, water-soluble prodrugs of corticosteroids has been developed. Two key requirements for dilute solution are (a) high solubility at the pH of optimum stability and (b) appropriate design of the pH-rate profile. Several 21-esters of methylprednisolone have been synthesized, and the rates of their aqueous solution hydrolysis have been determined to test the strategy. Compounds exhibiting estimated shelf lives in dilute solution of >2 years at 25°C have been identified.
View MoreZUNYI CITY BEI YUAN CHEMICAL CO., LTD
website:http://www.china-beiyuan.com
Contact:+86-851-27751258
Address:Shawan Town, Huichuan District, Zunyi City, Guizhou Province, China
Xi'an North Information Industry Co., Ltd. Weilv Chemical Department
Contact:+86-29-88156413
Address:Jixiang Road 99 Xi'an Shaanxi Province
Contact:+86-571-87010026
Address:202, Zhenhua Road,
Contact:+86-27-87204219, +86-27-87215023
Address:2402, HuiGu Space-time Building, 8 Forest Road, East Lake Hi-Tech Development Zone
Jinan Jianfeng Chemical Co., Ltd
Contact:0086-531-88110457
Address:sales01(-a-t-)pharmachemm{dot}c+o+m
Doi:10.1002/1521-4184(200110)334:10<305::AID-ARDP305>3.0.CO;2-O
(2001)Doi:10.1021/jo00216a049
(1985)Doi:10.1016/0020-1693(95)04515-5
()Doi:10.1016/0039-128X(64)90001-7
(1964)Doi:10.1007/BF00504416
(1985)Doi:10.1246/bcsj.58.521
(1985)